Stockscreener 앱 받기
0.3141
0.71%
0.00211
Lunai Bioworks Inc 주식(LNAI)의 최신 뉴스
Oncotelic Therapeutics Announces Closing of a Strategic - GlobeNewswire
Lunai Bioworks Stock: $20 Million Patent Deal Puts Nasdaq Fight in Focus - TechStock²
A $20M Lunai deal adds two routes past the blood-brain barrier - Stock Titan
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP - Morningstar
Lunai Bioworks Completes $20 Million Preferred Equity Issuance - Intellectia AI
Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com
Lunai Bioworks Acquires Neurobridge IP Holdings in Major Patent-Backed Merger, Issues Series B Preferred Stock - Minichart
Lunai Bioworks Completes Merger and Issues Preferred Stock - TipRanks
Lunai Bioworks Acquires Neurobridge IP in Stock Deal, Issuing $20M Series B Preferred - TradingView
Lunai Bioworks (NASDAQ: LNAI) files proxy supplement; Reverse Split on ballot - Stock Titan
Lunai Bioworks (NASDAQ: LNAI) issues $20M preferred to acquire CNS patents, aid Nasdaq equity test - Stock Titan
LNAI Lunai Bioworks reports Q1 2026 EPS of negative 0.08, shares slip 0.81 percent with no analyst earnings estimates.Open Stock Signal Network - Newser
Lunai Bioworks Inc. announced that it has received $20 million in funding - marketscreener.com
Why is this micro-cap biotech stock up 150% today? - MSN
What's Behind The Jump In Lunai Bioworks Stock? - MSN
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion - Quantisnow
SKAGI: Uppfærðar áherslur og skipulagsbreytingar - Weekly Voice
Lunai Bioworks, Inc. Announces Postponement of Special Meeting of Stockholders to May 8, 2026 - Weekly Voice
Lunai Bioworks Postpones Special Stockholder Meeting to May 8, 2026 to Ensure Quorum and Broker Voting Compliance 1 - Minichart
Lunai Bioworks Delays Special Stockholder Meeting to May - TipRanks
Lunai Bioworks (NASDAQ: LNAI) moves special vote to May 8 - Stock Titan
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data - Quantisnow
2 biotech stocks bridging the gap between unmet need and next-gen medicine - MSN
Lunai Bioworks completes $20M transaction to acquire BBB - MSN
2 biotech stocks bridging the gap between unmet need and next-gen medicine | 2026-04-27 | Investing News - Stockhouse
Is Lunai Bioworks (LNAI) stock gaining bullish momentum |Beat Estimates - Newser
Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED) - MSN
LNAI Lunai Bioworks reports Q1 2026 EPS of negative 8 cents with no consensus estimates, notching a 1.77 percent share gain today.Earnings Miss - Newser
Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED) - Benzinga
Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension - Benzinga
LNAI Should I Buy - Intellectia AI
Lunai Bioworks to effect 10:1 reverse stock split - MSN
Is Lunai Bioworks (LNAI) stock a strong buy | Q1 2026: Earnings ReportExpert Momentum Signals - Xã Thanh Hà
Lunai Bioworks (LNAI) Stock Fill Price (Investor Concern) 2026-04-20Momentum Surge - Cổng thông tin điện tử tỉnh Lào Cai
Lunai Bioworks unit secures defense collaboration for AI chemical threat platform - MSN
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships - Sahm
Lunai Bioworks signs letter of intent with Geneial for rare disease data collaboration - Investing.com Australia
0.78%
3.01%
자본화:
|
볼륨(24시간):